Clinical efficacy of SERMs.
作者信息
Dere W H
机构信息
Lilly Research Laboratories, USA.
出版信息
Aging (Milano). 1998 Apr;10(2):160-1.
PMID:9666217
Abstract
摘要
相似文献
1
Clinical efficacy of SERMs.
Aging (Milano). 1998 Apr;10(2):160-1.
2
Raloxifene: a selective estrogen receptor modulator.
Am Fam Physician. 1999 Sep 15;60(4):1131-9.
3
Next generation of SERMs being seen in clinic.
J Natl Cancer Inst. 1997 Jul 2;89(13):913.
4
[Estrogen receptor and selective estrogen receptor modulators (SERMs)].
Nihon Rinsho. 1999 May;57(5):1199-207.
5
Raloxifene: designer estrogen for preventing postmenopausal osteoporosis.
Can Fam Physician. 1999 May;45:1191-3.
6
A new alternative to estrogen: raloxifene.
Health News. 1998 Jun 25;4(8):4.
7
Tissue-specific estrogens--the promise for the future.
N Engl J Med. 1997 Dec 4;337(23):1686-7. doi: 10.1056/NEJM199712043372309.
8
Effects of raloxifene in postmenopausal women.
N Engl J Med. 1998 Apr 30;338(18):1313; author reply 1313-4. doi: 10.1056/NEJM199804303381814.
9
Raloxifene for postmenopausal osteoporosis.
Med Lett Drugs Ther. 1998 Mar 13;40(1022):29-30.
10
Raloxifene: a new class of anti-estrogens for the prevention of osteoporosis.
Nurse Pract. 1998 Sep;23(9):91-3.
Zotero 插件